384 related articles for article (PubMed ID: 28164238)
1. KLF13 is a genetic modifier of the Holt-Oram syndrome gene TBX5.
Darwich R; Li W; Yamak A; Komati H; Andelfinger G; Sun K; Nemer M
Hum Mol Genet; 2017 Mar; 26(5):942-954. PubMed ID: 28164238
[TBL] [Abstract][Full Text] [Related]
2. Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
van Ouwerkerk AF; Bosada FM; van Duijvenboden K; Houweling AC; Scholman KT; Wakker V; Allaart CP; Uhm JS; Mathijssen IB; Baartscheer T; Postma AV; Barnett P; Verkerk AO; Boukens BJ; Christoffels VM
Circulation; 2022 Feb; 145(8):606-619. PubMed ID: 35113653
[TBL] [Abstract][Full Text] [Related]
3. [Holt-Oram syndrome: family affected without TBX5 mutation and without phenotype manifestations in a probable mutation carrier].
Murga-Eizagaechevarria N; Garcia-Barcina M; Sarasola Diez E
Rev Esp Cardiol; 2011 Dec; 64(12):1225-6. PubMed ID: 21752519
[No Abstract] [Full Text] [Related]
4. TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome.
Guo DF; Li RG; Yuan F; Shi HY; Hou XM; Qu XK; Xu YJ; Zhang M; Liu X; Jiang JQ; Yang YQ; Qiu XB
Mol Med Rep; 2016 May; 13(5):4349-56. PubMed ID: 27035640
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 19a replacement partially rescues fin and cardiac defects in zebrafish model of Holt Oram syndrome.
Chiavacci E; D'Aurizio R; Guzzolino E; Russo F; Baumgart M; Groth M; Mariani L; D'Onofrio M; Arisi I; Pellegrini M; Cellerino A; Cremisi F; Pitto L
Sci Rep; 2015 Dec; 5():18240. PubMed ID: 26657204
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of two novel TBX5 variants present in individuals with Holt-Oram syndrome with different clinical manifestations.
Varela D; Varela T; Conceição N; Ferreira Â; Marques N; Silva AP; Azevedo P; Pereira S; Camacho A; de Jesus I; Cancela ML
Mol Genet Genomics; 2021 Jul; 296(4):809-821. PubMed ID: 33866394
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the clinical features of Holt-Oram syndrome resulting from missense and extended protein mutations of the TBX5 gene as well as TBX5 intragenic duplications.
Al-Qattan MM; Abou Al-Shaar H
Gene; 2015 Apr; 560(2):129-36. PubMed ID: 25680289
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterisation of Holt-Oram syndrome focusing on cardiac manifestations.
Jhang WK; Lee BH; Kim GH; Lee JO; Yoo HW
Cardiol Young; 2015 Aug; 25(6):1093-8. PubMed ID: 25216260
[TBL] [Abstract][Full Text] [Related]
9. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.
Smemo S; Campos LC; Moskowitz IP; Krieger JE; Pereira AC; Nobrega MA
Hum Mol Genet; 2012 Jul; 21(14):3255-63. PubMed ID: 22543974
[TBL] [Abstract][Full Text] [Related]
10. T-box genes and retinoic acid signaling regulate the segregation of arterial and venous pole progenitor cells in the murine second heart field.
De Bono C; Thellier C; Bertrand N; Sturny R; Jullian E; Cortes C; Stefanovic S; Zaffran S; Théveniau-Ruissy M; Kelly RG
Hum Mol Genet; 2018 Nov; 27(21):3747-3760. PubMed ID: 30016433
[TBL] [Abstract][Full Text] [Related]
11. Familial dilated cardiomyopathy associated with pathogenic TBX5 variants: Expanding the cardiac phenotype associated with Holt-Oram syndrome.
Patterson J; Coats C; McGowan R
Am J Med Genet A; 2020 Jul; 182(7):1725-1734. PubMed ID: 32449309
[TBL] [Abstract][Full Text] [Related]
12. TBX3 and TBX5 duplication: A family with an atypical overlapping Holt-Oram/ulnar-mammary syndrome phenotype.
Cenni C; Andres S; Hempel M; Strom TM; Thomas E; Davies A; Timoney N; Frigiola A; Logan M; Holder-Espinasse M
Eur J Med Genet; 2021 Jul; 64(7):104213. PubMed ID: 33930582
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing identifies a c.148-1G>C mutation of TBX5 in a Holt-Oram family with unusual genotype-phenotype correlations.
Guo Q; Shen J; Liu Y; Pu T; Sun K; Chen S
Cell Physiol Biochem; 2015; 37(3):1066-74. PubMed ID: 26401820
[TBL] [Abstract][Full Text] [Related]
14. Tbx5 inhibits hedgehog signaling in determination of digit identity.
Xu H; Xiang M; Qin Y; Cheng H; Chen D; Fu Q; Zhang KK; Xie L
Hum Mol Genet; 2020 Jun; 29(9):1405-1416. PubMed ID: 31373354
[TBL] [Abstract][Full Text] [Related]
15. A unique TBX5 microdeletion with microinsertion detected in patient with Holt-Oram syndrome.
Morine M; Kohmoto T; Masuda K; Inagaki H; Watanabe M; Naruto T; Kurahashi H; Maeda K; Imoto I
Am J Med Genet A; 2015 Dec; 167A(12):3192-6. PubMed ID: 26780237
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of novel TBX5 T-box mutations associated with Holt-Oram syndrome.
Boogerd CJ; Dooijes D; Ilgun A; Mathijssen IB; Hordijk R; van de Laar IM; Rump P; Veenstra-Knol HE; Moorman AF; Barnett P; Postma AV
Cardiovasc Res; 2010 Oct; 88(1):130-9. PubMed ID: 20519243
[TBL] [Abstract][Full Text] [Related]
17. HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1.
Ghosh TK; Aparicio-Sánchez JJ; Buxton S; Brook JD
Sci Rep; 2019 Nov; 9(1):17992. PubMed ID: 31784580
[TBL] [Abstract][Full Text] [Related]
18. Novel TBX5 duplication in a Japanese family with Holt-Oram syndrome.
Kimura M; Kikuchi A; Ichinoi N; Kure S
Pediatr Cardiol; 2015 Jan; 36(1):244-7. PubMed ID: 25274398
[TBL] [Abstract][Full Text] [Related]
19. Holt-Oram syndrome: clinical and molecular description of 78 patients with TBX5 variants.
Vanlerberghe C; Jourdain AS; Ghoumid J; Frenois F; Mezel A; Vaksmann G; Lenne B; Delobel B; Porchet N; Cormier-Daire V; Smol T; Escande F; Manouvrier-Hanu S; Petit F
Eur J Hum Genet; 2019 Mar; 27(3):360-368. PubMed ID: 30552424
[TBL] [Abstract][Full Text] [Related]
20. Novel compound heterozygous TBX5 variants may induce hypoplastic left heart syndrome.
Miyao N; Hirono K; Hata Y; Yoshimura N; Ichida F
Pediatr Int; 2019 Jun; 61(6):607-609. PubMed ID: 31215120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
